Last reviewed · How we verify
R-oxybutynin
At a glance
| Generic name | R-oxybutynin |
|---|---|
| Sponsor | Apnimed |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
- Crossover Trial of AD109 in Obstructive Sleep Apnea (PHASE2)
- OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER (PHASE3)
- Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- R-oxybutynin CI brief — competitive landscape report
- R-oxybutynin updates RSS · CI watch RSS
- Apnimed portfolio CI